News summary

Galvanize raises $130M to advance pulsed electric field ablation

Source: MedTech Dive • Published: 17 Nov 2026, 11:21

Summarized by Masters of Longevity from MedTech Dive.

Galvanize closed a $130 million Series D to commercialize Aliya PEF.

Galvanize raises $130M to advance pulsed electric field ablation
Key Takeaways
  • Series D funding is headed to Aliya commercialization efforts.
  • PEF is reported to kill cells while preserving tissue matrix.
  • RheOx development for chronic bronchitis is advancing in parallel.
Read the full article at MedTech Dive ↗

Continue exploring

Recommended MoL Picks

MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickLongevity is leaving the clinicStephen Watson argues that hotels, gyms and residential communities can build longevity memberships around the relationships they already have.